Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lobectomy-First Versus Lymphadenectomy-First Surgical Approach on Long-Term Survival in Operable Non-Small Cell Lung Cancer Patients: A Prospective, Multi-Center, Randomized Study

NCT06577792 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06577792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06577792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lobectomy-First Versus Lymphadenectomy-First Surgical Approach on Long-Term Survival in Operable Non-Small Cell Lung Cancer Patients: A Prospective, Multi-Center, Randomized Study
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 16, 2023
Completion date
April 20, 2031
Enrollment
620 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer